focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

2 Jul 2008 16:26

RNS Number : 1804Y
Chamberlin PLC
02 July 2008
 



CHAMBERLIN PLC (THE "COMPANY")

Directors' Dealings

The Company announces that on 2 July 2008, awards over ordinary shares with a nominal value of 25 pence each in the Company ("Shares") were made under the rules of the Chamberlin & Hill Performance Share Plan and the Chamberlin & Hill Share Option Plan to Directors of the Company, as follows:

Chamberlin & Hill Performance Share Plan ("PSP")

Director

Number of EMI options over Shares awarded 

Number of unapproved options over Shares awarded 

Total revised number of Shares over which options are held under the PSP

Tim Hair

11,940

14,925

76,860

Mark Bache

17,910

0

56,367

Adam Vickery

13,432

0

47,275

Under the PSP, awards are structured as nil-cost options granted under the Enterprise Management Incentives Scheme ("EMI") contained in Schedule 5 to the Income Tax (Earnings and Pensions) Act 2003. To the extent that an award is granted under the Plan in excess of the EMI individual limit of £120,000, the excess is treated as an Unapproved Option which is subject to the same terms as the EMI Option.

No consideration was paid for the grant of the Options.

The vesting of an Option is subject to the continued employment of the participant and the satisfaction of a performance condition set by the Remuneration Committee of the Company. The Option will normally become exercisable on the third anniversary of the date of grant subject to the satisfaction of a performance condition set by the Remuneration Committee of the Company.

To the extent that an EMI Option or any part of an EMI Option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant. To the extent that an Unapproved Option or any part of an Unapproved Option becomes exercisable, it remains exercisable for a period of 12 months from the date of vesting.

Chamberlin & Hill Share Option Plan ("SOP")

Director

Number of options over Shares awarded 

Total revised number of Shares over which options are held under the SOP

Tim Hair

303,680

505,962

Mark Bache

147,237

250,971

No consideration was paid for the grant of options under the SOP, which are structured as market value options.

The options will normally become exercisable in three equal tranches on each of the third, fourth and fifth anniversaries of the date of grant subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. To the extent that an option or any part of an option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant.

The option price payable by each participant on the exercise of his option is 163p.

The Company was informed of the above transactions under the PSP and SOP on 2 July 2008.

Enquiries:

Chamberlin plc

Tom Brown, Chairman 01922 707100

Tim Hair, Chief Executive  01922 707100

Landsbanki Securities (UK) Limited

Tom Hulme, NOMAD 020 7426 9000

Citigate Dewe Rogerson

Toby Mountford 07710 356611

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFIESASEEW
Date   Source Headline
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options
5th Jun 201811:45 amEQSHardman & Co Research: Chamberlin pLC (CMH): Trading strong, technical issues largely resolved
5th Jun 20187:00 amRNSFinal Results
9th May 20186:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.